Researcher
Michel De Vos
- Keywords:Medicine
- Disciplines:Reproductive medicine
Affiliations
- Follicle Biology (Research group)
Member
From1 Oct 2013 → Today - Centre for Reproductive Medicine - Gynaecology (Department)
Member
From1 Jan 2008 → Today - Clinical sciences (Department)
Member
From1 Apr 2022 → Today - Clinical sciences (Department)
Member
From1 Apr 2022 → 20 Oct 2022 - Surgical clinical sciences (Department)
Member
From8 Apr 2019 → 31 Mar 2022 - Surgical clinical sciences (Department)
Member
From1 Jan 2014 → 31 Mar 2022 - Surgical clinical sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2015 - Department of Embryology and Genetics (Department)
Member
From1 Oct 2013 → 31 Dec 2013 - Department of Embryology and Genetics (Department)
Member
From1 Oct 2009 → 31 Dec 2013 - Gyneacology-Urology (Department)
Member
From1 Mar 2009 → 28 Feb 2010
Projects
1 - 2 of 2
- Financing IOF-program: 4R-ART: Clinical validation of optimized In Vitro Maturation and of Oocyte Quality Test for registration purposesFrom1 Jan 2015 → 31 Dec 2019Funding: IOF - Industrial Research Fund
- Investigation of epigenetic stability and safety of assisted reproduction technologiesFrom1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
Publications
21 - 30 of 108
- Perspectives on the development and future of oocyte IVM in clinical practice(2021)
Authors: Michel De Vos, Michaël Grynberg, Manh Tuong Ho, Ye Yuan, David F Albertini, Robert B Gilchrist
Pages: 1265-1280 - Ovarian tissue cryopreservation and transplantation in patients with central nervous system tumours(2021)
Authors: Thu Yen Thi Nguyen, Luciana Cacciottola, Alessandra Camboni, Joachim Ravau, Michel De Vos, Isabelle Demeestere, Jacques Donnez, Marie Madeleine Dolmans
Pages: 1296-1309 - IVF in women aged 43 years and older(2021)
Authors: Alice Machado Fernandez, Panagiotis Drakopoulos, Jerome Rosetti, Valerie Uvin, Shari Mackens, Erlisa Bardhi, Michel De Vos, Michel Camus, H Tournaye, Michaël De Brucker
Pages: 768-773 - Improved clinical outcomes after non-invasive oocyte selection and Day 3 eSET in ICSI patients(2021)
Authors: Inge Van Vaerenbergh, Tom Adriaenssens, Wim Coucke, Lisbet Van Landuyt, Greta Verheyen, Michaël De Brucker, Michel Camus, Peter Platteau, Michel De Vos, Elien Van Hecke, et al.
- Impact of ARTs on oncological outcomes in young breast cancer survivors(2021)
Authors: M Condorelli, Michel De Vos, S Lie Fong, C. Autin, A. Delvigne, F Vanden Meerschaut, C Wyns, R Imbert, C Cheruy, J Bouziotis, et al.
Pages: 381-389 - Personalized ovarian stimulation based on expected number of euploid embryos(2021)
Authors: Panagiotis Drakopoulos, Christophe Blockeel, Antonis Makrigiannakis, Michel De Vos, Herman Tournaye, Nicola Pluchino
Pages: 261-262 - Follitropin alpha versus beta in a first GnRH antagonist ICSI cycle(2021)
Authors: Lien Van Den Haute, Panagiotis Drakopoulos, Greta Verheyen, Michel De Vos, Herman Tournaye, Christophe Blockeel
Pages: 655-662 - A View from the past into our collective future(2021)
Authors: Teresa K Woodruff, Lauren Ataman-Millhouse, Kelly S Acharya, Teresa Almeida-Santos, Antoinette Anazodo, Richard A Anderson, Leslie Appiah, Joy Bader, Kerri Becktell, Robert E Brannigan, et al.
Pages: 3-15 - The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF/ICSI for high responders(2020)
Authors: Samuel Santos-Ribeiro, Shari Mackens, Biljana Popovic-Todorovic, A Racca, Nikolaos P Polyzos, Lisbet Van Landuyt, P Drakopoulos, Michel De Vos, H Tournaye, Christophe Blockeel
Pages: 2808-2818 - Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy(2020)
Authors: Cynthia D'Hondt, Marian Vanhoeij, Ellen Van Moer, Ingrid Segers, Christel Fontaine, Herman Tournaye, Michel De Vos
Pages: 433-444